Possible Bearish Signals With USANA Health Sciences Insiders Disposing Stock
Possible Bearish Signals With USANA Health Sciences Insiders Disposing Stock
The fact that multiple USANA Health Sciences, Inc. (NYSE:USNA) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, if numerous insiders are selling, shareholders should investigate more.
在過去的一年中,多位USANA Health Sciences, Inc.(紐約證券交易所代碼:USNA)內部人士拋售了大量股票,這一事實可能會引起投資者的關注。在評估內幕交易時,了解內部人士是否在買入通常更有幫助,因爲內幕賣出可以有多種解釋。但是,如果有許多內部人士出售,股東應該進行更多調查。
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.
儘管我們認爲股東不應簡單地關注內幕交易,但我們確實認爲密切關注內部人士的所作所爲是完全合乎邏輯的。
USANA Health Sciences Insider Transactions Over The Last Year
去年的USANA健康科學內幕交易
Over the last year, we can see that the biggest insider sale was by the insider, Jim Brown, for US$811k worth of shares, at about US$66.48 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$49.71. So it is hard to draw any strong conclusion from it.
在過去的一年中,我們可以看到,最大的內幕出售是知情人吉姆·布朗,以每股約66.48美元的價格出售了價值81.1萬美元的股票。雖然我們通常不喜歡看到內幕銷售,但更令人擔憂的是是否以較低的價格進行銷售。令人欣慰的是,此次出售的價格遠高於當前的股價,即49.71美元。因此,很難從中得出任何強有力的結論。
Insiders in USANA Health Sciences didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
去年,USANA健康科學的內部人士沒有購買任何股票。你可以在下面看到過去 12 個月內幕交易(公司和個人)的直觀描述。通過點擊下面的圖表,你可以看到每筆內幕交易的確切細節!
For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
對於那些喜歡尋找中獎投資的人來說,這份最近有內幕收購的成長型公司的免費名單可能只是門票。
Insiders At USANA Health Sciences Have Sold Stock Recently
USANA Health Sciences的內部人士最近出售了股票
We have seen a bit of insider selling at USANA Health Sciences, over the last three months. insider John Fleming sold just US$16k worth of shares in that time. It's not great to see insider selling, nor the lack of recent buyers. But the volume sold is so low that it really doesn't bother us.
在過去的三個月中,我們看到了USANA Health Sciences的一些內幕拋售。內部人士約翰·弗萊明當時僅出售了價值1.6萬美元的股票。看到內幕銷售或缺少近期買家都不是一件好事。但是銷量太低了,真的不打擾我們。
Insider Ownership Of USANA Health Sciences
USANA 健康科學的內部所有權
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that USANA Health Sciences insiders own 41% of the company, worth about US$379m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
查看公司的內部持股總量可以幫助你了解他們是否與普通股股東保持一致。通常,內部人士的所有權越高,內部人士長期建立公司的可能性就越大。很高興看到USANA健康科學內部人士擁有該公司41%的股份,價值約3.79億美元。內部人士的這種重要所有權通常會增加公司爲所有股東的利益而經營的機會。
What Might The Insider Transactions At USANA Health Sciences Tell Us?
USANA Health Sciences的內幕交易能告訴我們什麼?
While there has not been any insider buying in the last three months, there has been selling. But given the selling was modest, we're not worried. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the USANA Health Sciences insiders selling. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of USANA Health Sciences.
儘管在過去三個月中沒有任何內幕買盤,但一直在拋售。但鑑於拋售幅度不大,我們並不擔心。很高興看到高水平的內部所有權,但回顧去年,我們並沒有從USANA Health Sciences內部人士的拋售中獲得信心。因此,雖然了解內部人士在買入或賣出方面的所作所爲很有幫助,但了解特定公司面臨的風險也很有幫助。爲了幫助解決這個問題,我們發現了一個警告信號,你應該仔細觀察一下,以更好地了解USANA Health Sciences。
But note: USANA Health Sciences may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
但請注意:USANA健康科學可能不是最值得購買的股票。因此,來看看這份投資回報率高、負債率低的有趣公司的免費清單。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。